Pancreastatin is a 49 amino acid peptide with a C-terminal glycine ami
de originally isolated from porcine pancreas. There are strong indicat
ions that pancreastatin is derived from chromogranin A, since the amin
o acid sequence 240-288 in porcine chromogranin A contains pancreastat
in flanked by typical signals for proteolytic processing. Several mole
cular forms of immunoreactive pancreastatin have been reported to be p
resent in porcine adrenal medulla, but no information on the secretion
of the peptides is available. We studied stimuli for the release of i
mmunoreactive pancreastatin from adrenal glands as well as the molecul
ar nature of the released immunoreactivity using isolated, perfused, p
orcine adrenal glands with intact splanchnic nerve supply and a radioi
mmunoassay specific for the C-terminal glycine amide of porcine pancre
astatin in combination with chromatography. Stimulation of the splanch
nic nerves greatly enhanced the release of immunoreactive pancreastati
n by a mechanism that seems to involve cholinergic nicotinic transmiss
ion. The pancreastatin immunoreactivity was due to large amounts of a
N-terminally extended pancreastatin form, possibly corresponding to th
e chromogranin A(1-288) fragment and small amounts of pancreastatin an
d a C-terminal pancreastatin fragment. Adrenal extracts also contained
unprocessed chromogranin A. We conclude that in the porcine adrenals
at least 25% of chromogranin A is processed to smaller molecular forms
with the pancreastatin sequence forming their C-terminus. These forms
appear to be released in parallel with the catecholamines.